$FANGZHOU JIANKE (06086.HK)$The official launch of the initial public offering was on June 28th. The company plans to globally issue 23.8 million shares, of which 2.38 million shares are sold in Hong Kong and 21.42 million shares are sold internationally, with an additional 15% over-allotment option. Citigroup and Bank of Agriculture and Rural Development International are joint sponsors; it is expected that the shares will begin trading on the Main Board of the Stock Exchange of Hong Kong on July 9, 2024.

Let's take a closer look at the IPO situation of Ark Pharmacy (6086.HK) below.